B00001: In the Statement, Page 1, lines 12 and 13, "gastro-intestinal diseases, genitourinary diseases" should be deleted, and, "gastrointestinal diseases, genitourinary disorders" should be inserted, and, In the Statement, Page 1, line 15, "use in the" should be deleted, and, In the Statement,Page 1, lines 16-18, "neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system," should be deleted, and, In the Statement, Page 1, line 19, "diseases of the circulatory system," should be deleted, and, "circulatory diseases," should be inserted, and, In the Statement, Page 1, line 20, "headaches, migraines," should be deleted, and, In the Statement, Page 1, line 21, "in liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, "preparations" should be deleted, and, "products" should be inserted and In the Statement, Page 1, lines 25 and 28, "the" should be deleted, and, In the Statement, Page 1, line 27, " immunological diseases" should be deleted, and, "immunological disorders" should be inserted, and, In the Statement, Page 1, line 30, " headaches, migraines" should be deleted, and, In the Statement, Page 1, line 31, "liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, In the Statement, Page 1, line 34, after USE, "; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 2,"ophthalmological" should be deleted, and, "ophthalmic" should be inserted, and, In the Statement, Page 2, line 5, "use" should be deleted, and, "purposes" should be inserted, and, In the Statement, Page 2, line, 8, "consulting" should be deleted, and, "consultancy" should be inserted, and, In the Statement, Page 2, line 9, "any kind of" should be deleted, and, "all" should be inserted, and, In the Statement, Page 2, lines 11 and 12, "trade fairs or congresses for business" should be deleted, and, "trade fairs and conventions for commercial" should be inserted, and, In the Statement, Page 2, line 14, after PRODUCTS, "; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 16, after SERVICES, "; all the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted.
CD0000: The mark consists of the word "Exeltis" in dark blue, in rounded font and with the first letter capitalized, under which there is the phrase "Rethinking healthcare" in light blue, also in rounded font but smaller in size lower and with only the first letter of the first word capitalized. To the left of these words is a logo in dark blue and light blue consisting of seven leaves of diminishing size linked at their bases and opening in array with tips pointing outwards.
GS0051: Pharmaceutical preparations for [ use in ] the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, gynecological diseases and disorders; reagents for use in pregnancy tests; medical diagnostic reagents for use in ovulation tests; medical diagnostic reagents for use in testing for diabetes; contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, [ vascular diseases, ] [ gastro-intestinal diseases, genitourinary diseases, ] * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for [ use in the ] treatment of [ neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, ] diseases of the musculoskeletal system, diseases of the respiratory system, [ diseases of the circulatory system, ] * circulatory diseases, * viral diseases, glaucoma, dental and mouth diseases, [ headaches, migraines, ] obesity, cholesterol, [ in liver treatment ] * treatment of the liver * ; nutraceutical preparations for use as a dietary supplement; pharmaceutical [ preparations ] * products * for treating blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, [ the ] treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological [ diseases, ] * disorders, * infectious diseases, inflammatory diseases, metabolic diseases and disorders, [ the ] [ treatment of neurological diseases, ] the treatment of viral diseases, glaucoma, dental and oral diseases, [ headaches, migraines, ] obesity, [ liver treatment ] * treatment of the *, cholesterol; nutraceutical veterinary preparations for use as a dietary supplement; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods, namely, crackers adapted for medical use * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
B00002: In the statement, Page 2, line 7, "all" should be deleted, and "none of" should be inserted.
B00003: In the statement, Page 1, line 5 "USE IN" should be deleted. In the statement, Page 1, line 12, "VASCULAR DISEASES," should be deleted. In the statement, Page 1, lines 27-28, "TREATMENT OF NEUROLOGICAL;" should be deleted.
CC0000: The color(s) dark blue and light blue is/are claimed as a feature of the mark.
GS0351: Sales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; presentation of goods on [ any kind of ] * all * communication media for retail sale; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
DS0000: "HEALTHCARE"
GS0101: [ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]
GS0421: [ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]
Case File Event Statements
2/24/2014 - 10 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
2/21/2014 - 10 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
2/24/2014 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
2/24/2014 - 10 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
2/25/2014 - 10 years ago
5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
2/25/2014 - 10 years ago
6 - REFUSAL PROCESSED BY MPUType:RFRR
2/25/2014 - 10 years ago
7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
2/28/2014 - 10 years ago
8 - APPLICATION FILING RECEIPT MAILEDType:MAFR
3/14/2014 - 10 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
8/25/2014 - 10 years ago
10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP
Trademark
79142730
